当前位置:产品中心>单抗/多抗

Anti-Human CD274/PD-L1/B7-H1 & PD-1 Bispecific Reference Antibody|抗人CD274/PD-L1/B7-H1和PD-1双特异性参考抗体(靶标:人PD-L1/PD-1)

货号:RB9T37015601
  • 价格:面议
  • 点击数:558
  

产品介绍

产品参数

形态Liquid
宿主种属Human
克隆性Monoclonal
抗体亚型Ig(G1-kappa_G1-lambda2)
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度2.23mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, Programmed cell death protein 1, Protein PD-1, hP
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号Q9NZQ7 & Q15116
背景信息Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research.<br>
别名Bispecific, IBI318, IBI-318, IBI318, 2445259-99-2
备注For research use only. Not suitable for clinical or therapeutic use.